NCT04503681

Brief Summary

Patients diagnosed with cancer commonly have a high degree of anxiety during an initial oncology consultation, which may interfere with a patient's ability to retain information required to make informed treatment decisions. A previous study randomized breast cancer survivors (volunteers) to view either (a) a brief video depicting a standard initial consultation from an oncologist or (b) an identical consultation with the addition of compassionate statements from the oncologist, and found the compassionate statements reduced anxiety among the volunteers. However, it is currently unknown if watching a video containing compassionate statements from an oncologist prior to an actual initial oncology consultation will reduce anxiety among patients referred to a cancer center. The aim of this randomized control trial is to test if watching a brief video containing compassionate statements from an oncologist, compared to watching a standard introduction video, prior to an initial oncology consultation will reduce the degree of anxiety among patients referred to a cancer center. This is a prospective, randomized controlled clinical trial at an academic cancer center. The investigators will enroll adult patients scheduled for an initial oncology consultation. Subjects will be randomly assigned to receive a "standard introduction video" or "enhanced compassion video" for viewing prior to the initial oncology consultation. On arrival to the cancer center anxiety severity will be measured using the Hospital Anxiety and Depression scale (HADS). The HADS has two 7-item subscales (HADS Anxiety and HADS Depression) and is well-validated among oncology patients. Wilcoxon rank-sum test will be used to test for a difference in the HADS subscales between the two video groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
374

participants targeted

Target at P75+ for not_applicable cancer

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 7, 2020

Completed
10 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

November 21, 2024

Completed
Last Updated

November 21, 2024

Status Verified

October 1, 2024

Enrollment Period

2.4 years

First QC Date

August 4, 2020

Results QC Date

July 8, 2024

Last Update Submit

October 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anxiety Subscale of the Hospital Anxiety and Depression Scale (HADS)

    Seven item subscale. Each item is scored on a 4-point scale (0=not at all to 3=nearly all the time); thus, range from 0-21. Higher score indicates greater anxiety.

    Baseline (on arrival to the cancer center for an initial oncology consultant).

Secondary Outcomes (1)

  • Depression Subscale of the Hospital Anxiety and Depression Scale

    Baseline (on arrival to the cancer center for an initial oncology consultant).

Study Arms (2)

Standard introduction video

ACTIVE COMPARATOR
Other: Standard introduction video

Enhanced compassion video

EXPERIMENTAL
Other: Enhanced compassion video

Interventions

Added five additional sentences to the standard introduction video. Those five sentences were compassion-focused statements. The compassionate statements added to the "enhanced compassion video" were based on the results of a recent systematic review of clinician compassionate behaviors, which found incorporating statements of support, acknowledgement, patient's perspective, emotion naming, and validation increased patient perception of compassion.

Enhanced compassion video

Standard introduction video sent to a new patient via email introducing the new patient to the cancer center prior to the initial consultation.

Standard introduction video

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥ 18 years
  • scheduled for an initial oncology consultation

You may not qualify if:

  • patients who do not have an active email address or are medically unable to complete the research questionnaire at the time of the initial cancer consultation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cooper University Health Care

Camden, New Jersey, 08103, United States

Location

Related Publications (2)

  • Winn C, Grana G, Mazzarelli A, Nicholson A, Mykulowycz K, Obiakor C, Bair A, Trzeciak S, Roberts B. Preconsultation compassion video to reduce anxiety among patients referred to a cancer centre: a randomised control trial. BMJ Oncol. 2024 Aug 6;3(1):e000427. doi: 10.1136/bmjonc-2024-000427. eCollection 2024.

  • Winn C, Generosa G, Mazzarelli A, Trzeciak S, Roberts BW. Preconsultation compassion intervention to reduce anxiety among patients referred to a cancer center: protocol for a randomised control trial. BMJ Open. 2021 May 24;11(5):e048201. doi: 10.1136/bmjopen-2020-048201.

MeSH Terms

Conditions

NeoplasmsAnxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Results Point of Contact

Title
Brian Roberts
Organization
Cooper University Health Care

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Director

Study Record Dates

First Submitted

August 4, 2020

First Posted

August 7, 2020

Study Start

June 1, 2021

Primary Completion

October 31, 2023

Study Completion

October 31, 2023

Last Updated

November 21, 2024

Results First Posted

November 21, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

After review and approval by our study data use committee, we will allow other researchers who submit to us a suitable protocol to have access to the complete de-identified datasets used and/or analyzed during the study, in comma separated value format together with a data dictionary.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE

Locations